Leveraging high-resolution omics data for predicting responses and adverse events to immune checkpoint inhibitors

A long-standing goal of personalized and precision medicine is to enable accurate prediction of the outcomes of a given treatment regimen for patients harboring a disease. Currently, many clinical trials fail to meet their endpoints due to underlying factors in the patient population that contribute...

Descripción completa

Detalles Bibliográficos
Autores principales: Limeta, Angelo, Gatto, Francesco, Herrgård, Markus J., Ji, Boyang, Nielsen, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432706/
https://www.ncbi.nlm.nih.gov/pubmed/37602228
http://dx.doi.org/10.1016/j.csbj.2023.07.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432706/
https://www.ncbi.nlm.nih.gov/pubmed/37602228
http://dx.doi.org/10.1016/j.csbj.2023.07.032

Ejemplares similares